Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertensive End-Organ Damage”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Post-approval studies (Phase 4)Study completedNCT01872039
What this trial is testing

Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

Who this might be right for
Hypertension EmergencyEnd-organ Damage
Astellas Pharma China, Inc. 163
Not applicableUnknownNCT04213963
What this trial is testing

Prospective Study on Primary Aldosteronism in Resistant Hypertension

Who this might be right for
Resistant HypertensionPrimary AldosteronismRefractory Hypertension+3 more
University of Turin, Italy 100